Results 241 to 250 of about 130,099 (348)

Unusual Disease‐Progression in Two Siblings With Xeroderma Pigmentosum Group G

open access: yesClinical Genetics, EarlyView.
Protein truncation mutations in the gene for XPG nuclease cause a very severe clinical phenotype. Two siblings have splicing mutations, which result in in‐frame deletions and a less severe phenotype.
Elena Botta   +4 more
wiley   +1 more source

Formaldehyde Emissions From 2‐Octyl Cyanoacrylate: Quantified Risk for Allergic Contact Dermatitis

open access: yesContact Dermatitis, EarlyView.
This study found that 2‐octyl cyanoacrylate skin adhesives release formaldehyde at levels up to 8.4× above EPA dermal thresholds and up to 2.41× above NIOSH airborne limits, producing exposures sufficient to provoke allergic and irritant contact dermatitis in patients.
Daniel S. Rouhani   +6 more
wiley   +1 more source

PS49. Shifted Circadian Phase in Manic Episode was Returned to Normal after Treatment in Bipolar Disorder [PDF]

open access: yes, 2016
Cho, Chul-Hyun   +13 more
core  

Epicutaneous and Drug Provocation Testing in Severe Cutaneous Adverse Reactions: A 20‐Year Single‐Centre Experience

open access: yesContact Dermatitis, EarlyView.
This study provides reassuring evidence in favour of early skin testing in patients with SCARs, argues against the necessity of a 6‐month delay, and underscores the pivotal role of oral provocation tests in the safe reintroduction of essential therapies. ABSTRACT Background Identifying and discontinuing the offending drug(s) in severe cutaneous adverse
Zohra Chadli   +8 more
wiley   +1 more source

Safety and effectiveness of the combination of 5‐azacitidine and ruxolitinib in VEXAS syndrome: A single‐centre experience

open access: yes
British Journal of Haematology, EarlyView.
Gregorio Maria Bergonzi   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy